AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On May 30, 2025,
(COR) saw a significant increase in trading volume, with a turnover of $11.34 billion, marking a 325.81% rise from the previous day. This surge placed Cencora at the 119th position in the daily stock market rankings. The stock price of Cencora rose by 0.19%, marking the second consecutive day of gains, with a total increase of 0.71% over the past two days.Cencora's robust performance can be attributed to its strong U.S. Healthcare Solutions business and recent product launches. The company's revenue for the quarter ending March 31, 2025, was $75.45 billion, reflecting a 10.29% growth. This brings the company's revenue for the last twelve months to $310.23 billion, indicating a 12.18% year-over-year growth. The company's earnings per share (EPS) for the quarter ending May 7, 2025, was $4.42, surpassing expectations.
Investor confidence in Cencora is further bolstered by recent investments. 111 Capital invested $716,000 in the company, highlighting the market's positive outlook. Additionally, the company's dividend of $0.55 per share, with an ex-dividend date of May 16, 2025, provides a stable income stream for shareholders. The short interest in Cencora's stock stands at 6.06 million shares as of May 15, 2025, indicating a moderate level of bearish sentiment.
Hunt down the stocks with explosive trading volume.

Jan.02 2026

Jan.02 2026

Jan.02 2026

Jan.02 2026

Jan.02 2026
Daily stocks & crypto headlines, free to your inbox
Comments

No comments yet